NOVT - Novanta Inc.
NASDAQ
->
Technology
->
Scientific & Technical Instruments
Bedford,
United States
Type: Equity
NOVT price evolution
NOVT
| (in millions $) | 27 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $98.47 | $93.52 | $105.05 | |
| Short term investments | ||||
| Net receivables | $177.35 | $145.03 | $150.91 | $139.41 |
| Inventory | $154.02 | $160.04 | $161.37 | $149.37 |
| Total current assets | $436.93 | $424.79 | $428.82 | $415.3 |
| Long term investments | ||||
| Property, plant & equipment | $164.24 | $158.4 | $158.11 | $147.75 |
| Goodwill & intangible assets | $793.97 | $804.95 | $629.53 | |
| Total noncurrent assets | $973.78 | $981.78 | $810.76 | |
| Total investments | ||||
| Total assets | $1418.82 | $1398.57 | $1410.59 | $1226.06 |
| Current liabilities | ||||
| Accounts payable | $68.72 | $71.04 | $71.4 | $57.2 |
| Deferred revenue | ||||
| Short long term debt | $14.57 | $14.09 | $13.16 | |
| Total current liabilities | $156.6 | $153.47 | $151.41 | $139.18 |
| Long term debt | $455.87 | $518.39 | $551.78 | $386.75 |
| Total noncurrent liabilities | $543.11 | $577.47 | $413.42 | |
| Total debt | $532.96 | $565.87 | $399.91 | |
| Total liabilities | $676.63 | $696.58 | $728.88 | $552.6 |
| Shareholders' equity | ||||
| Retained earnings | $251.09 | $231.89 | $218.14 | $203.46 |
| Other shareholder equity | -$12.67 | -$27.38 | -$28.15 | -$24.04 |
| Total shareholder equity | $701.99 | $681.72 | $673.46 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $105.05 | $100.11 | $117.39 | $125.05 |
| Short term investments | ||||
| Net receivables | $139.41 | $139.21 | $115.62 | $75.05 |
| Inventory | $149.37 | $168 | $125.66 | $92.74 |
| Total current assets | $415.3 | $420.52 | $373.82 | $304.17 |
| Long term investments | ||||
| Property, plant & equipment | $147.75 | $146.5 | $135.78 | $113.12 |
| Goodwill & intangible assets | $629.53 | $654.66 | $700.49 | $434.5 |
| Total noncurrent assets | $810.76 | $820.69 | $854.06 | $561.01 |
| Total investments | ||||
| Total assets | $1226.06 | $1241.21 | $1227.88 | $865.18 |
| Current liabilities | ||||
| Accounts payable | $57.2 | $75.22 | $68.51 | $42.97 |
| Deferred revenue | ||||
| Short long term debt | $13.16 | $12.59 | $12.43 | $11.7 |
| Total current liabilities | $139.18 | $164.52 | $183.94 | $114.23 |
| Long term debt | $386.75 | $435.31 | $475.06 | $227.73 |
| Total noncurrent liabilities | $413.42 | $499.1 | $522.65 | $274.14 |
| Total debt | $399.91 | $484.06 | $487.49 | $239.43 |
| Total liabilities | $552.6 | $663.63 | $706.59 | $388.37 |
| Shareholders' equity | ||||
| Retained earnings | $203.46 | $130.58 | $56.53 | $6.2 |
| Other shareholder equity | -$24.04 | -$32.01 | -$12.87 | -$12.24 |
| Total shareholder equity | $673.46 | $577.59 | $521.29 | $476.81 |
| (in millions $) | 27 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $244.41 | $235.86 | $230.92 | $211.57 |
| Cost of revenue | $132.18 | $130.5 | $115.01 | |
| Gross Profit | $109.22 | $103.69 | $100.42 | $96.56 |
| Operating activities | ||||
| Research & development | $23.73 | $23.25 | $23.45 | |
| Selling, general & administrative | $44.79 | $43.53 | $41.7 | |
| Total operating expenses | $74.16 | $77.97 | $74.81 | $74.88 |
| Operating income | $25.71 | $25.61 | $21.68 | |
| Income from continuing operations | ||||
| EBIT | $25.4 | $25.17 | $21.67 | |
| Income tax expense | $5.03 | $3.38 | $2.24 | $3.23 |
| Interest expense | -$8.28 | $8.27 | $8.25 | $5.92 |
| Net income | ||||
| Net income | $19.19 | $13.76 | $14.68 | $12.51 |
| Income (for common shares) | $13.76 | $14.68 | $12.51 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $881.66 | $860.9 | $706.79 | $590.62 |
| Cost of revenue | $481.76 | $482.43 | $406.46 | $346.11 |
| Gross Profit | $399.9 | $378.47 | $300.33 | $244.52 |
| Operating activities | ||||
| Research & development | $91.68 | $85.77 | $72.52 | $61 |
| Selling, general & administrative | $164.46 | $158.9 | $129.16 | $109.85 |
| Total operating expenses | $289.4 | $275.39 | $236.27 | $188.63 |
| Operating income | $110.5 | $103.08 | $64.05 | $55.89 |
| Income from continuing operations | ||||
| EBIT | $109.57 | $102.78 | $63.56 | $54.97 |
| Income tax expense | $10.87 | $13.11 | $5.84 | $3.88 |
| Interest expense | $25.82 | $15.62 | $7.39 | $6.56 |
| Net income | ||||
| Net income | $72.88 | $74.05 | $50.33 | $44.52 |
| Income (for common shares) | $72.88 | $74.05 | $50.33 | $44.52 |
| (in millions $) | 27 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $13.76 | $14.68 | $12.51 | |
| Operating activities | ||||
| Depreciation | $14.12 | $12.93 | $11.55 | |
| Business acquisitions & disposals | -$191.2 | |||
| Stock-based compensation | $6.23 | $6.08 | $7.21 | |
| Total cash flows from operations | $41.09 | $32.83 | $38.99 | |
| Investing activities | ||||
| Capital expenditures | -$4.94 | -$6.42 | -$6.15 | |
| Investments | ||||
| Total cash flows from investing | -$206.11 | -$4.94 | -$197.62 | -$6.15 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$31.37 | $162.02 | -$4.5 | |
| Total cash flows from financing | $92.56 | -$32.02 | $153.46 | -$5.07 |
| Effect of exchange rate | $4.24 | $0.81 | -$0.21 | $1.32 |
| Change in cash and equivalents | -$12.36 | $4.95 | -$11.53 | $29.09 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $72.88 | $74.05 | $50.33 | $44.52 |
| Operating activities | ||||
| Depreciation | $46.61 | $53.16 | $43.39 | $38.29 |
| Business acquisitions & disposals | -$23.04 | -$286.93 | -$2.63 | |
| Stock-based compensation | $25.59 | $23.11 | $25.61 | $23.12 |
| Total cash flows from operations | $120.08 | $90.78 | $94.63 | $140.24 |
| Investing activities | ||||
| Capital expenditures | -$19.89 | -$19.51 | -$19.78 | -$10.52 |
| Investments | ||||
| Total cash flows from investing | -$19.89 | -$42.54 | -$306.7 | -$13.16 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$10 | -$5.5 | ||
| Net borrowings | -$86.55 | $8.42 | $237.99 | -$37.01 |
| Total cash flows from financing | -$97.85 | -$60.15 | $204.75 | -$84.36 |
| Effect of exchange rate | $2.62 | -$5.37 | -$0.34 | $3.38 |
| Change in cash and equivalents | $4.95 | -$17.29 | -$7.66 | $46.11 |
News
Fundamentals
| Market cap | $5.92B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 35.92M |
| Revenue | $922.75M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $60.13M |
| Revenue Q/Q | 10.34% |
| Revenue Y/Y | 3.86% |
| P/E ratio | 98.38 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 6.41 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $1.67 |
|---|---|
| ROA | 4.41% |
| ROE | N/A |
| Debt/Equity | 0.82 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.79 |
| Quick ratio | 1.81 |